Science and Enterprise

Category: Joint ventures/collaborations

  • Sanofi Division, Max Planck to Partner on Retinal Research

    Max Planck Society in Germany and Fovea Pharmaceuticals in Paris have agreed to a research and licensing agreement on therapies for restoring vision to patients with diseases affecting the retina. Fovea is the ophthalmology division of the French drug company Sanofi-Aventis. Fovea’s team plans to work with the Max Planck Institute of Biophysics in Frankfurt…

  • Cardiac Device Infections Linked to Higher Costs, Mortality

    A team of academic and industry researchers have found an association between infections from cardiovascular implantable electronic devices (CIEDs) and increases in mortality and hospital care costs. The findings from this study appear online in the journal Archives of Internal Medicine (paid subscription required). The researchers, led by Muhammad Sohail, from the Mayo Clinic College…

  • Consortium Funds Semiconductor Research in Emirates

    Semiconductor Research Corporation (SRC), a university-research consortium in Durham, North Carolina, announced seven research contracts will be awarded to four universities in the United Arab Emirates (UAE). The new contracts continue the joint effort between SRC and the Advanced Technology Investment Company (ATIC) in the UAE begun last year on semiconductor sciences and technologies. The…

  • Non-Native Insects Costing Local Governments, Homeowners

    Scientists from U.S. and Canadian universities and the U.S. Forest Service built a statistical model to compute the cost of damage caused by invasive tree-feeding insects that are inadvertently imported to the U.S. The team from the National Center for Ecological Analysis and Synthesis (NCEAS) at University of California in Santa Barbara published their findings…

  • University, Company Partner on Contraband Nuclear Detector

    Researchers at University of New Hampshire in Durham and Michigan Aerospace Corporation in Ann Arbor have received a contract from the U.S. Defense Threat Reduction Agency to build an instrument to accurately detect illicit radioactive materials from a safe distance. The one-year contract of $303,000 calls for a realistic field test of the device in…

  • U.S., China Universities to Collaborate on Cancer Biomarkers

    Arizona State University in Tempe and Sun Yat-Sen University (SYSU) in Guangzhou, China have agreed to collaborate on research developing early and predictive diagnostics for colorectal cancer. The agreement involves the Biodesign Institute’s Center for Sustainable Health at ASU and the SYSU Gastrointestinal Institute of the Sixth Affiliated Hospital in Guangzhou. Research scientists at the…

  • New Method Can Increase Commercial Antibiotic Yields

    Researchers from the U.K. and Japan have devised a new method for increasing the yields of antibiotic compounds from bacteria. The process, which has practical applications in commercial pharmaceutical production, is scheduled to be described this week in an online issue of the journal Proceedings of the National Academy of Sciences. Most known antibiotics are…

  • Insomnia Costs U.S. Employers Billions in Lost Productivity

    Researchers from universities, hospitals, and companies in the U.S. and Europe calculated the lost productivity of Americans suffering from insomnia at an annual cost of $63.2 billion to employers. Their findings from the study, funded by the pharmaceutical company Merck, appear in the 1 September issue of the journal Sleep (paid subscription required). The team…

  • Improved Cellulose Processing Developed for Biofuels

    A team of university and industry researchers in Europe and the U.S.  have developed a process to hasten the breakdown of cellulose in waste plant matter for conversion to ethanol. Their findings appear online in the journal Proceedings of the National Academy of Sciences. Scientists with the company Novozymes in Davis, California, and Bagsvaerd, Denmark,…

  • Computer Model Tests Effects of Heart Rhythm Drugs

    Researchers at University of California in Davis have led the development of a computer model to test the effects of medications for arrhythmia — abnormal heart rhythm — before they are given to patients. The work of the team led by biophysicist Colleen Clancy is described in the 31 August issue of the journal Science…